马方旭,邹芳,赵娟,刘亚群,王布.lncRNA-miR210HG在NSCLC患者癌组织中的表达及其临床意义.[J].中南医学科学杂志.,2024,(2):240-242, 246.
lncRNA-miR210HG在NSCLC患者癌组织中的表达及其临床意义
Expression and clinical significance of lncRNA-miR210HG in cancer tissues of NSCLC patients
投稿时间:2023-05-08  修订日期:2024-01-13
DOI:10.15972/j.cnki.43-1509/r.2024.02.020
中文关键词:  非小细胞肺癌  癌组织  lncRNA-miR210HG  临床病理参数 [
英文关键词:non-small cell lung cancer  cancer tissue  lncRNA-miR210HG  clinicopathological parameter
基金项目:河北省医学科学研究课题计划(20231415)
作者单位E-mail
马方旭 河北省胸科医院呼吸与危重症医学科,河北石家庄050041 e-mail为jgfd20230317@163.com,e-mail为kacc20230113@163.com 
邹芳 河北北方学院附属第一医院呼吸与危重症医学科,河北张家口075000  
赵娟 河北省胸科医院呼吸与危重症医学科,河北石家庄050041  
刘亚群 河北北方学院附属第一医院呼吸与危重症医学科,河北张家口075000  
王布 河北北方学院附属第一医院呼吸与危重症医学科,河北张家口075000 e-mail为jgfd20230317@163.com,e-mail为kacc20230113@163.com 
摘要点击次数: 32
全文下载次数: 31
中文摘要:
      目的分析非小细胞肺癌(NSCLC)患者癌组织中长链非编码RNA(lncRNA)-miR210HG的表达及其临床意义。 方法选取84例NSCLC患者,比较其癌组织及癌旁组织中lncRNA-miR210HG水平。按照lncRNA-miR210HG表达水平将患者分为高表达组和低表达组,比较两组临床病理参数和生存情况。多因素COX回归模型分析影响NSCLC患者预后的危险因素。 结果NSCLC癌组织miR210和lncRNA-miR210HG表达水平均高于癌旁组织(P<0.05)。Ⅲ期、存在淋巴结转移的患者癌组织中lncRNA-miR210HG高表达者占比较高(P<0.05),高表达组总生存率和无进展生存率低于低表达组(P<0.05)。lncRNA-miR210HG是影响NSCLC患者预后的独立危险因素(P<0.05)。 结论NSCLC癌组织中lncRNA-miR210HG高表达与有无淋巴转移、临床分期有关,lncRNA-miR210HG是影响NSCLC患者预后的独立危险因素。
英文摘要:
      AimTo analyze the expression and clinical significance of long non-coding RNA (lncRNA)-miR210HG in cancer tissues of patients with non-small cell lung cancer (NSCLC). MethodsA total of 84 patients with NSCLC were enrolled. The level of lncRNA-miR210HG in cancer tissues and para-carcinoma tissues was compared. According to average expression level of lncRNA-miR210HG, patients were divided into high-expression group and low-expression group, respectively, and clinicopathological parameters and survival in these two groups were compared. The risk factors affecting prognosis of NSCLC patients were analyzed by multivariate COX regression model. ResultsThe expression levels of miR210 and lncRNA-miR210HG in cancer tissues were higher than those in para-carcinoma tissues (P<0.05). The proportion of high-expression lncRNA-miR210HG was higher in patients with clinical staging at stage III and lymph node metastasis (P<0.05). The overall survival rate and progression-free survival rate in high-expression group were lower than those in low-expression group (P<0.05). The lncRNA-miR210HG was an independent risk factor to affect prognosis of NSCLC patients (P<0.05). ConclusionThe high expression of lncRNA-miR210HG in cancer tissues is related to lymph node metastasis and clinical staging in NSCLC. The lncRNA-miR210HG is an independent risk factor to affect prognosis of NSCLC patients.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=C84FD2BF879E04694224F41F878D61AA56A2F33B81852AE31179CEBBF85695833AAE12091EDCFE7B399719C5B214FD1B1A167C614AB461E1A6BA2054556A9F0E52BB785F38CAE19E9DEC8297A79EB0A2691EACAF18F73DCA8E6B4A7534E95142&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=B80136CCD8DCBAA1&aid=&vid=&iid=0B39A22176CE99FB&sid=C812B90E96151014&eid=388A1EC957C62F9F50BE585EFF5DCE81&fileno=20240220&flag=1&is_more=0">